The final, formatted version of the article will be published soon.
ORIGINAL RESEARCH article
Front. Pharmacol.
Sec. Pharmacology of Anti-Cancer Drugs
Volume 15 - 2024 |
doi: 10.3389/fphar.2024.1501849
This article is part of the Research Topic Advancements in the Heterogeneity of Sex for Tumors View all 7 articles
CSNK1E is involved in TGF-β1 induced Epithelial Mesenchymal Transformationas and related to melanoma immune heterogeneity
Provisionally accepted- 1 Jiangxi Maternal and Child Health Hospital, Nanchang, Jiangxi Province, China
- 2 Medical Center of Burn Plastic and Wound Repair, The First Affiliated Hospital of Nanchang University, 330006 Jiangxi, China, Nanchang, China
- 3 Department of Plastic and Aesthetic Surgery, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, China
Melanoma (MM) is the deadliest skin cancer originating from melanocytes. Despite advancements in immunotherapy that have somewhat improved MM prognosis, high levels of resistance continue to result in poor outcomes. In this study, we analyzed the expression patterns and potential mechanisms of WNT signaling pathway genes in MM. Using Cox regression, we identified 19 prognostic-related genes and performed consistency clustering to explore the potential of WNT pathway genes as classifiers for prognosis. We further refined these genes using the Least Absolute Shrinkage and Selection Operator (LASSO) algorithm to construct a 13-gene prognostic model.This model demonstrated excellent predictive performance and validation at multiple time points. We found that CSNK1E and RAC3 were significantly positively correlated with the epithelial-to-mesenchymal transition (EMT) process, with CSNK1E exhibiting a similar expression trend to EMT-related genes. Additionally, these two genes were negatively correlated with multiple immune cell types and immune checkpoint genes. Pan-cancer analysis revealed the heterogeneous expression and prognostic potential of CSNK1E across various cancers. Wet experiments confirmed that CSNK1E promotes MM proliferation, invasion, and migration, and enhances malignant progression through the TGF-β pathway. These findings highlight the potential of CSNK1E as therapeutic targets in MM, and suggest that the WNT and TGF-β pathways have a synergistic role in the EMT process.
Keywords: CSNK1E, TGF-β 1, Epithelial Mesenchymal Transformationa, Melanoma, LASSO
Received: 25 Sep 2024; Accepted: 28 Nov 2024.
Copyright: © 2024 Hong, Wang, Huang, Chen, Liu, zheng, Chen, Xie, Zhan, You and Huang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Pengfei Chen, Jiangxi Maternal and Child Health Hospital, Nanchang, Jiangxi Province, China
Yifan Liu, Jiangxi Maternal and Child Health Hospital, Nanchang, Jiangxi Province, China
Ziying zheng, Jiangxi Maternal and Child Health Hospital, Nanchang, Jiangxi Province, China
Yinghua Chen, Jiangxi Maternal and Child Health Hospital, Nanchang, Jiangxi Province, China
Zengxin Xie, Jiangxi Maternal and Child Health Hospital, Nanchang, Jiangxi Province, China
Gongnan Zhan, Jiangxi Maternal and Child Health Hospital, Nanchang, Jiangxi Province, China
Xin You, Jiangxi Maternal and Child Health Hospital, Nanchang, Jiangxi Province, China
Heping Huang, Jiangxi Maternal and Child Health Hospital, Nanchang, Jiangxi Province, China
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.